Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells

Autor: Massacci, Giorgia, Venafra, Veronica, Zwiebel, Maximilian, Wahle, Maria, Cerroni, Rocco, Bissacco, Jacopo, Perfetto, Livia, Michienzi, Vito, Stefani, Alessandro, Mercuri, Nicola Biagio, Schirinzi, Tommaso, Sacco, Francesca

Publikováno v: In Neurobiology of Disease 1 October 2024 200

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A key role of the WEE1-CDK1 axis in mediating TKI-therapy resistance in FLT3-ITD positive acute myeloid leukemia patients.

Autor: Massacci G; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Venafra V; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Latini S; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Bica V; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Pugliese GM; Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy., Graziosi S; PhD Program in Cellular and Molecular Biology, Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Klingelhuber F; Institute for Diabetes and Obesity, Helmholtz Zentrum München, German Center for Diabetes Research, 85764, Neuherberg, Germany., Krahmer N; Institute for Diabetes and Obesity, Helmholtz Zentrum München, German Center for Diabetes Research, 85764, Neuherberg, Germany., Fischer T; Institute of Molecular and Clinical Immunology, University of Magdeburg, Magdeburg, Germany.; Healthcampus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany., Mougiakakos D; Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany., Boettcher M; Healthcampus for Inflammation, Immunity and Infection (GCI3), University of Magdeburg, Magdeburg, Germany.; Department of Hematology and Oncology, University of Magdeburg, Magdeburg, Germany., Perfetto L; Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy. livia.perfetto@uniroma1.it.; Department of Biology, Fondazione Human Technopole, Via Rita Levi-Montalcini 1, 20157, Milan, Italy. livia.perfetto@uniroma1.it., Sacco F; Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Rome, Italy. francesca.sacco@uniroma2.it.; Telethon Institute of Genetics and Medicine (TIGEM), Via Campi Flegrei 34, Pozzuoli, 80078, Italy. francesca.sacco@uniroma2.it.

Publikováno v: Leukemia [Leukemia] 2023 Feb; Vol. 37 (2), pp. 288-297. Date of Electronic Publication: 2022 Dec 12.